natgillin/translations-raw huggingface dataset:
The clinical signs (lethargy, tachycardia, tremors, ataxia, uncoordinated movement, hyperaemia of the eye, ocular discharge, protrusion of the 3rd eyelid and blepharospasm) were comparable in frequency and severity between the different dose groups.
Klinični znaki (letargija, tahikardija, tremor, ataksija, nekoordinirano gibanje, hiperemija očesa, izcedek iz očesa, protruzija tretje veke in blefarospazem) so bili glede na pogostost in resnost primerljivi med različnimi skupinami odmerkov.
When a quantity of 6 or 8 drops is to be administered, the dose should be divided into 2 alternate administrations given 1-2 minutes apart.
Kadar je potrebna količina zdravila 6 ali 8 kapljic, je treba odmerek razdeliti na dve odmerjanji s premorom 1-2 minuti.
Other medicines that have antiemetic properties, such as metoclopramide, chlorpromazine, acepromazine, maropitant or antihistamines may diminish the effectiveness of ropinirole.
Druga zdravila, ki imajo antiemetične lastnosti, kot so metoklopramid, klorpromazin, acepromazin, maropitant ali antihistaminiki, lahko zmanjšajo učinkovitost ropinirola.
METHOD AND ROUTE(S) OF ADMINISTRATION Ocular use.
NAČIN IN POT(I) UPORABE Okularna uporaba.
The product is to be administered into the eye, at a dose of 1-8 eye drops.
Zdravilo je treba dati v oko, v odmerku 1-8 kapljic.
CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Veterinary medicinal product subject to prescription.
POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE Na veterinarski recept.
The safety of this product in dogs with clinical signs due to the ingestion of foreign materials has not been investigated.
Varnost zdravila pri psih, ki imajo klinične znake zaradi zaužitja tujkov, ni raziskana.
In case of a pre-existing ocular condition with clinical signs, use the product only according to the benefitrisk assessment by the responsible veterinarian.
V primeru že obstoječe bolezni oči s kliničnimi znaki uporabite zdravilo le v skladu z oceno razmerja korist/tveganje odgovornega veterinarja.
For example, for the administration of 6 drops: administer 2 drops into the right eye and 2 drops into the left eye, then after 1-2 minutes pause administer a further 1 drop into each eye.
Primer pri dajanju 6 kapljic: dajte 2 kapljici v desno oko in 2 kapljici v levo oko ter po 1-2 minutah premora še po 1 kapljico v vsako oko.
Store the container in the pouch in order to protect from light.
Vsebnik shranjujte v vrečki, da se zaščiti pred svetlobo.
For example, for the administration of 3 drops: administer 2 drops into the right eye and 1 drop into the left eye.
Primer pri dajanju 3 kapljic: dajte 2 kapljici v desno oko in 1 kapljico v levo oko.
Low density polyethylene plastic single-dose container containing 0.6 ml.
Enoodmerni plastični vsebnik iz polietilena nizke gostote, ki vsebuje 0,6 ml raztopine.
Hold the container in an upright position without touching the eye. Rest your little finger on the forehead of the dog to maintain the distance between the container and the eye.
Držite mezinec na čelu psa, da ohranite razdaljo med vsebnikom in očesom.
Be careful not to touch the dropper tip after opening the container.
Pazite, da se po odprtju vsebnika ne dotaknete konice kapalke.
In dogs with protracted vomiting (more than 60 minutes) and other clinical signs related to the pharmacological action of the active substance (e.g. ocular hyperaemia, tachycardia, tremors or shaking), dopamine antagonists such as metoclopramide or domperidone may be used to manage these clinical signs.
Pri psih z dolgotrajnim bruhanjem (več kot 60 minut) in drugimi kliničnimi znaki, povezanimi s farmakološkim delovanjem učinkovine (npr. očesna hiperemija, tahikardija, tremor ali tresenje), se lahko za obvladovanje teh kliničnih znakov uporabljajo antagonisti dopamina, kot sta metoklopramid ali domperidon.
Within 30 minutes 95% of the dogs vomited.
95 % psov je začelo bruhati v 30 minutah.
Do not use in cases of the ingestion of sharp foreign objects, corrosive agents (acids or alkalis), volatile substances or organic solvents.
Ne uporabite v primeru zaužitja ostrih tujkov, korozivnih sredstev (kislin ali lugov), hlapnih snovi ali organskih topil.
Very common reactions: temporary mild or moderate redness of the eye, increased tear production, increased visibility of the third eyelid and/or squinting; temporary mild tiredness and/or increased heart rate.
Zelo pogosti neželeni učinki: začasna blaga ali zmerna pordelost očesa, povečano nastajanje solz, povečana vidnost tretje veke in/ali mežikanje; začasna blaga utrujenost in/ali pospešen srčni utrip.
This veterinary medicinal product can cause eye irritation.
To zdravilo za uporabo v veterinarski medicini lahko povzroči draženje oči.
Ropinirole might reduce the level of prolactin, a hormone that stimulates milk production in pregnant or breast-feeding women.
Ropinirol lahko zniža raven prolaktina, hormona, ki spodbuja proizvodnjo mleka pri samicah v obdobju brejosti in laktacije.
EXPIRY DATE EXP: {month/year}
DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA EXP: {mesec/leto}
An additional dose was administered after 20 minutes to 13% of the dogs because of lack of efficacy.
Zaradi pomanjkanja učinkovitosti je 13 % psov po 20 minutah dobilo dodaten odmerek.
The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Pogostost neželenih učinkov je določena po naslednjem dogovoru: - zelo pogosti (neželeni učinki se pokažejo pri več kot 1 od 10 zdravljenih živali) - pogosti (pri več kot 1, toda manj kot 10 živali od 100 zdravljenih živali) - občasni (pri več kot 1, toda manj kot 10 živali od 1000 zdravljenih živali) - redki (pri več kot 1, toda manj kot 10 živali od 10.000 zdravljenih živali) - zelo redki (pri manj kot 1 živali od 10.000 zdravljenih živali, vključno s posameznimi primeri).
About 40% of radioactive ropinirole is excreted in the urine within 24 hours after intravenous administration to dogs.
Po intravenskem dajanju psom se približno 40 % radioaktivnega ropinirola izloči z urinom v 24 urah.
ADVICE ON CORRECT ADMINISTRATION The veterinary medicinal product should only be administered by a veterinarian or under their close supervision.
NASVET O PRAVILNI UPORABI ZDRAVILA Zdravilo za uporabo v veterinarski medicini sme dajati samo veterinar oziroma se sme dajati samo pod natančnim nadzorom veterinarja.
The half-life of elimination (t½) is 4 hours after intravenous administration to dogs.
Razpolovni čas izločanja (t½) pri psih je po intravenskem dajanju 4 ure.
The veterinary medicinal product should not be administered by pregnant or breast-feeding women.
Tega zdravila za uporabo v veterinarski medicini ne smejo dajati nosečnice ali doječe matere.
Dopamine antagonists (such as metoclopramide), neuroleptics (e.g., chlorpromazine, acepromazine) and other medicinal products with antiemetic properties (e.g., maropitant or antihistamines) may reduce the effectiveness of this veterinary medicinal product.
Antagonisti dopamina (npr. metoklopramid), nevroleptiki (npr. klorpromazin, acepromazin) in druga zdravila z antiemetičnimi lastnostmi (npr. maropitant ali antihistaminiki) lahko zmanjšajo učinkovitost tega zdravila za uporabo v veterinarski medicini.
MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
PROIZVAJALEC, ODGOVOREN ZA SPROŠČANJE SERIJ
The dose is equivalent to 2-15 µl/kg bw in dogs.
Pri psih odmerek ustreza 2-15 µl/kg telesne mase.
Ropinirole inhibits prolactin secretion by activation of dopamine D2 receptors located in the striatum and on lactotroph cells of pituitary gland.
Ropinirol zavira izločanje prolaktina z aktiviranjem receptorjev dopamina D2, ki so v striatumu in na laktotropnih celicah hipofize.
EU/2/17/222/001 - 1 single-dose container EU/2/17/222/002 - 2 single-dose containers EU/2/17/222/003 - 4 single-dose containers EU/2/17/222/004 - 5 single-dose containers EU/2/17/222/005 - 6 single-dose containers EU/2/17/222/006 - 8 single-dose containers EU/2/17/222/007 - 10 single-dose containers EU/2/17/222/008 - 3 single-dose containers
EU/2/17/222/001 - 1 enoodmerni vsebnik EU/2/17/222/002 - 2 enoodmerna vsebnika EU/2/17/222/003 - 4 enoodmerni vsebniki EU/2/17/222/004 - 5 enoodmernih vsebnikov EU/2/17/222/005 - 6 enoodmernih vsebnikov EU/2/17/222/006 - 8 enoodmernih vsebnikov EU/2/17/222/007 - 10 enoodmernih vsebnikov EU/2/17/222/008 - 3 enoodmernih vsebnikov
Transient, mild conjunctival swelling, itching of the eyes, tachypnoea, tremors, diarrhoea, ataxia and uncoordinated movement.
Prehodno blago otekanje veznice, srbenje oči, tahipneja, tremor, driska, ataksija in nekoordinirano gibanje.
Ropinirole is metabolised by the liver.
Ropinirol se presnavlja v jetrih.
The veterinary medicinal product should only be administered by a veterinarian or under their close supervision.
Zdravilo za uporabo v veterinarski medicini sme dajati samo veterinar oziroma se sme dajati samo pod natančnim nadzorom veterinarja.
Ropinirole might reduce the level of prolactin due to its inhibitory effect on prolactin secretion as a dopamine agonist.
Ropinirol lahko zniža raven prolaktina, saj ima kot agonist dopamina zaviralni učinek na izločanje prolaktina.
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Cardboard box
PODATKI NA ZUNANJI OVOJNINI Kartonasta škatla
No direct correlation between ropinirole concentration in plasma and the duration of vomiting was observed after ocular administration.
Po dajanju v oko niso opazili neposredne korelacije med koncentracijo ropinirola v plazmi in trajanjem bruhanja.
Administer the product with caution.
Pri dajanju tega zdravila je potrebna previdnost.
Be careful not to touch the dropper tip after opening the container in case a second dose is necessary.
Pazite, da se po odprtju vsebnika ne dotaknete konice kapalke; to je pomembno, če bo potreben še drugi odmerek.
EU/2/17/222/001 - 1 single-dose container EU/2/17/222/002 - 2 single-dose containers EU/2/17/222/003 - 4 single-dose containers EU/2/17/222/004 - 5 single-dose containers EU/2/17/222/005 - 6 single-dose containers
EU/2/17/222/001 - 1 enoodmerni vsebnik EU/2/17/222/002 - 2 enoodmerna vsebnika EU/2/17/222/003 - 4 enoodmerni vsebnik EU/2/17/222/004 - 5 enoodmernih vsebnikov EU/2/17/222/005 - 6 enoodmernih vsebnikov EU/2/17/222/006 - 8 enoodmernih vsebnikov EU/2/17/222/007 - 10 enoodmernih vsebnikov EU/2/17/222/008 - 3 enoodmernih vsebnikov
Ropinirole (µg/body surface area)
Ropinirol (μg/telesno površino)
The safety of the product has not been studied in dogs with diagnosed cardiac disease/dysfunction.
Pri psih z diagnosticirano boleznijo/disfunkcijo srca varnosti zdravila niso preučili.
THE WORDS “FOR ANIMAL TREATMENT ONLY” For animal treatment only.
BESEDILO „SAMO ZA ŽIVALI“ Samo za živali.
PHARMACEUTICAL FORM Eye drops, solution in single-dose container
FARMACEVTSKA OBLIKA Kapljice za oko, raztopina v enoodmernem vsebniku
The safety of the veterinary medicinal product has not been established during pregnancy and lactation in the target species.
Varnost zdravila v obdobju brejosti in laktacije pri ciljni živalski vrsti ni bila ugotovljena.
QUANTITY OF THE ACTIVE SUBSTANCE(S) 30 mg/ml ropinirole
KOLIČINA UČINKOVIN(E) 30 mg/ml ropinirola
The safety and efficacy of the product have not been studied in dogs with ocular disease or injury.
Pri psih z boleznijo ali poškodbo oči niso preučili varnosti in učinkovitosti zdravila.
If the dog does not vomit within 15 minutes after administration of the initial dose, a second dose may be given 15 to 20 minutes after administration of the initial dose.
Če pes ne bruha v 15 minutah po dajanju začetnega odmerka, mu lahko od 15 do 20 minut po začetnem odmerku daste še drugi odmerek.
EXPIRY DATE EXP {month/year} Once opened use within 30 minutes.
Odprto zdravilo uporabite v 30 minutah.
Common reactions: temporary, mild swelling of the mucous membranes of the eyelids, itching of the eyes, rapid breathing, shivering, diarrhoea and/or irregular or uncoordinated bodily movements.
Pogosti neželeni učinki: začasno blago otekanje sluznice vek, srbenje oči, hitro dihanje, drgetanje, driska in/ali neenakomerno ali nekoordinirano gibanje telesa.
Ropinirole is mainly eliminated by hepatic metabolism.
Ropinirol se v glavnem izloča s presnovo v jetrih.
Common adverse reactions:
Pogosti neželeni učinki:
Therefore, use of the product is not recommended during pregnancy or lactation.
Zato uporaba zdravila v obdobju brejosti in laktacije ni priporočljiva.
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Pouch label
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
The following dosing table provides the dose in drops to be administered corresponding to the dog's bodyweight.
V naslednji preglednici za odmerjanje so navedeni odmerki v kapljicah, ki jih je treba uporabiti glede na telesno maso psa.
PHARMACEUTICAL FORM Eye drops solution in single-dose container.
FARMACEVTSKA OBLIKA Kapljice za oko, raztopina v enoodmernem vsebniku.
30 mg (equivalent to 34.2 mg ropinirole hydrochloride) Excipients:
Ropinirol (ropinirole) 30 mg (ustreza 34,2 mg ropinirolijevega hidroklorida)
The following dosing table provides the dose volume in drops to be administered corresponding to the dog's bodyweight.
V naslednji preglednici za odmerjanje so navedeni volumni odmerkov v kapljicah, ki jih je treba uporabiti glede na telesno maso psa.
The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s) - common (more than 1 but less than 10 animals in 100 animals treated)
Pogostost neželenih učinkov je določena po naslednjem dogovoru: - zelo pogosti (neželeni učinki se pokažejo pri več kot 1 od 10 zdravljenih živali) - pogosti (pri več kot 1, toda manj kot 10 živali od 100 zdravljenih živali) - občasni (pri več kot 1, toda manj kot 10 živali od 1000 zdravljenih živali) - redki (pri več kot 1, toda manj kot 10 živali od 10.000 zdravljenih živali)
After opening place the container back into the pouch, in case a second dose is necessary.
SHRANITEV ODPRTEGA VSEBNIKA: Po odprtju dajte vsebnik nazaj v vrečko, če bo potreben še en odmerek.
Very common adverse reactions: Transient mild or moderate hyperaemia of the eye, ocular discharge, protrusion of the 3rd eyelid and blepharospasm.
Prehodna blaga ali zmerna hiperemija očesa, izcedek iz oči, protruzija tretje veke in blefarospazem.
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
- zelo redki (pri manj kot 1 živali od 10.000 zdravljenih živali, vključno s posameznimi primeri).
STATEMENT OF ACTIVE SUBSTANCES 30 mg/ml ropinirole
NAVEDBA UČINKOVIN(E) 30 mg/ml ropinirola
The time to last vomit ranged from 30 to 82 minutes following ocular administration in a pharmacokinetic study in dogs.
V študiji farmakokinetike pri psih se je čas do zadnjega bruhanja gibal med 30 in 82 minutami po dajanju v oko.
Excretion in the urine occurs mainly as metabolites.
Učinkovina se izloča z urinom predvsem v obliki presnovkov.
Dog bodyweight (kg)
Telesna masa psa (kg)
Ropinirole is rapidly absorbed into the systemic circulation of dogs after administration as a solution on their eye surface.
Pri psih se ropinirol po dajanju raztopine na očesno površino hitro absorbira v sistemski krvni obtok.
Uncommon adverse reactions: Corneal ulceration.
Občasni neželeni učinki: Razjede roženice.
Clevor 30 mg/ml eye drops, solution is supplied in single-dose containers containing 0.6 ml.
Zdravilo Clevor 30 mg/ml kapljice za oko, raztopina, je na voljo v enoodmernih vsebnikih po 0,6 ml. Vsak vsebnik je zaprt v posamezno vrečko iz laminirane aluminijaste folije.
QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of solution contains:
KAKOVOSTNA IN KOLIČINSKA SESTAVA
NAME OF THE VETERINARY MEDICINAL PRODUCT Clevor 30 mg/ml eye drops, solution in single-dose container for dogs Ropinirole (ropinirol)
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Clevor 30 mg/ml kapljice za oko, raztopina v enoodmernem vsebniku za pse Ropinirol (ropinirole)
Ask your veterinarian or pharmacist how to dispose of medicines no longer required.
ZDRAVILA ALI ODPADNIH SNOVI, ČE OBSTAJAJO Glede odstranjevanja zdravil, ki jih ne uporabljate več, se posvetujte z veterinarjem ali farmacevtom.
NAME OF THE VETERINARY MEDICINAL PRODUCT Clevor ropinirole
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI
NAME OF THE VETERINARY MEDICINAL PRODUCT Clevor 30 mg/ml eye drops, solution for dogs ropinirole
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Clevor 30 mg/ml kapljice za oko, raztopina za pse ropinirol
PACKAGE LEAFLET: Clevor 30 mg/ml eye drops, solution in single-dose container for dogs
NAVODILO ZA UPORABO Clevor 30 mg/ml kapljice za oko, raztopina v enoodmernem vsebniku za pse
Instructions for administration
Navodila za dajanje
The safety of the product has not been studied in dogs with hepatic impairment.
Pri psih z okvaro jeter varnosti zdravila niso preučili.
Squeeze the prescribed number of drops into the eye(s).
Stisnite predpisano število kapljic v eno ali obe očesi.
NAME OF THE VETERINARY MEDICINAL PRODUCT Clevor 30 mg/ml eye drops, solution in single-dose container for dogs
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Clevor 30 mg/ml kapljice za oko, raztopina v enoodmernem vsebniku za pse
WASTE MATERIALS, IF ANY
UPORABE, ČE JE SMISELNO
72 hours.
72 ur.
Human albumin.
Humani albumin.
Date of first authorisation: 23 March 2018
Datum prve odobritve: 23. marec 2018
• These shall contain the following key elements:
• Ta gradiva morajo vsebovati naslednje ključne elemente:
EXP {XX-XXX-XXXX at XX:XX CET}
EXP {XX-XXX-XXXX ob XX:XX CET}
In addition a long term follow-up was conducted up to Week 52.
Poleg tega je potekalo še dolgoročno spremljanje do 52. tedna.
• The educational material for health professionals should contain:
• Izobraževalno gradivo za zdravstvene delavce mora vsebovati:
Do not give this medicine to children and adolescents (i.e. aged under 18 years) because the potential benefits and risks are unknown.
Tega zdravila ne smete dati otrokom in mladostnikom (tj. osebam, mlajšim od 18 let), ker morebitne koristi in tveganja niso znani.
In general, these side effects are quite mild and disappear in the days following the fistula procedure.
Na splošno so ti neželeni učinki dokaj blagi in izginejo v dneh po postopku na fistuli.
The safety and efficacy of darvadstrocel in children and adolescents aged 0 to 17 years have not yet been established.
Varnost in učinkovitost darvadstrocela pri otrocih in mladostnikih, starih od 0 do 17 let, še nista bili dokazani.
This medicine contains cells of human origin.
Zdravilo vsebuje celice humanega izvora.
This should be considered if you are allergic to these antibiotics, as these antibiotics are used in the manufacturing process of this medicine.
To je treba upoštevati, če ste alergični na ta antibiotika, saj se antibiotika uporabljata pri postopku izdelave zdravila.
Final Report to EMA: 2Q/3Q 2022
Končno poročilo za agencijo EMA: 2Q/3Q 2022
The recommended dose is 120 million cells.
Priporočeni odmerek je 120 milijonov celic.
6 mL 30 million cells
6 ml 30 milijonov celic
The efficacy of Alofisel was assessed in the ADMIRE-CD study.
Učinkovitost zdravila Alofisel so ocenili v študiji ADMIRE-CD.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor/surgeon for advice before you are given this medicine.
Če ste noseči ali dojite, menite, da bi lahko bili noseči ali načrtujete zanositev, se posvetujte z zdravnikom/kirurgom, preden vam dajo to zdravilo.
Common side effects (may affect up to 1 to 10 patients):
Pogosti neželeni učinki (lahko se pojavijo pri največ 1 od 10 bolnikov):
The frequency of adverse reactions is defined using the following convention: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000) and not known (cannot be estimated from available data).
Pogostnost neželenih učinkov je opredeljena na naslednji način: zelo pogosti (≥ 1/10); pogosti (≥ 1/100 do < 1/10); občasni (≥ 1/1.000 do < 1/100); redki (≥ 1/10.000 do < 1/1.000); zelo redki (< 1/10.000) in neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov).
*Conditioning reactions occurring up to seven days after the fistula cleaning for treatment administration.
* Reakcije na pripravo, ki se pojavijo največ sedem dni po čiščenju fistule za dajanje zdravila.
The product is checked at different stages during its manufacture to ensure that it is free of infection.
Zdravilo v različnih fazah izdelave preverjajo, da zagotovijo, da ni okuženo.
• procedural pain (pain after fistula cleaning)
• bolečina zaradi postopka (bolečina po čiščenju fistule)
This should be considered in patients with known hypersensitivity to these classes of antibiotics.
To je treba upoštevati pri bolnikih z znano preobčutljivostjo na te skupine antibiotikov.
Injection
injekcija
Women of childbearing age should use effective contraception during treatment with Alofisel.
Ženske v rodni dobi morajo med zdravljenjem z zdravilom Alofisel uporabljati učinkovito kontracepcijo.
Control group (Placebo+standard of care*) N= 102
Kontrolna skupina (placebo + standardna oskrba*) N = 102
• Guide for health professionals providing information on potential for microbial information and advice on steps to follow in case a positive culture is identified.
• Vodnik za zdravstvene delavce, ki zagotavlja informacije o možnosti mikrobne kontaminacije in nasvete za ukrepe v primeru identifikacije pozitivne kulture.
This means that with a dose of 120 million cells it is possible to treat up to three fistula tracts that open to the perianal area.
To pomeni, da je z odmerkom 120 milijonov celic mogoče zdraviti največ tri trakte fistule, ki se odpirajo v perianalno območje.
Pharmacotherapeutic group: {not yet assigned}, ATC code: {not yet assigned}.
Farmakoterapevtska skupina: {še ni bila dodeljena}, oznaka ATC: {še ni bila dodeljena}.
Once you have been anaesthetised (general or regional anaesthesia), your surgeon will:
Ko boste pod anestezijo (splošno ali regionalno), bo kirurg:
In the unlikely event that the results detected an infection, your treatment team will be informed who will tell you if you need any laboratory tests of treatment for the infection.
Če rezultati slučajno pokažejo okužbo, bo vaša zdravniška ekipa obveščena in vam bodo povedali, ali potrebujete kakršne koli laboratorijske teste ali zdravljenje okužbe.
2.1 General description
2.1 Splošen opis
Adult stem cells are a special type of cells found in many adult tissues, whose primary role is the repair of the tissue in which they are found.
Odrasle matične celice so posebne celice, ki jih najdemo v številnih odraslih tkivih, njihova prvotna naloga pa je popravljanje tkiva, v katerem se nahajajo.
C/ Marconi, 1, Parque Tecnológico de Madrid, 28760 Tres Cantos, Madrid, Spain
C/ Marconi, 1, Parque Tecnológico de Madrid, 28760 Tres Cantos, Madrid, Španija
• clean the fistulas with salt water and remove any scar tissue.
• očistil fistule s slano vodo in odstranil brazgotinasto tkivo.
Parque Tecnológico de Madrid 28760 Tres Cantos, Madrid Spain
Parque Tecnológico de Madrid 28760 Tres Cantos, Madrid Španija
The aim of the educational programme is to provide information on how to correctly administer the product in order to minimise the risk of medication errors and to increase awareness about the potential transmission of infectious agents.
Namen izobraževalnega programa je zagotoviti informacije o pravilni uporabi zdravila, da se zmanjša tveganje za napake pri zdravljenju, in povečati zavedanje o morebitnem prenašanju povzročiteljev okužb.
GLASS VIAL
STEKLENA VIALA
Do not irradiate or otherwise sterilise.
Ne obsevajte ali drugače sterilizirajte.